[Clinical experiences with peroral administration of antidiabetic drug BZ-55 (invenol)].
D003920:Diabetes Mellitus / Q000628:therapy*; D006801:Humans; D007004:Hypoglycemic Agents; D000077145:Sulfanilamide; D013424:Sulfanilamides / Q000031:analogs & derivatives; D014508:Urea / Q000031:analogs & derivatives
D007004:Hypoglycemic Agents; D013424:Sulfanilamides; D000077145:Sulfanilamide; D014508:Urea
DIABETES MELLITUS/therapy; SULFANILAMIDE/related compounds; UREA/related compounds
Klinische Erfahrungen mit dem peroral wirksamen Antidiabeticum BZ 55 (Invenol).